Proportions, absolute numbers and cytotoxicity of circulating NK cells are decreased in SLE patients, particularly in patients with active disease, e.g. lupus nephritis, and especially CD226+ NK cells (12–16). The gene discussed is CD226; the disease is systemic lupus erythematosus.